PhaseBio Pharmaceuticals Inc. (PHAS) Announces CFO Resignation

November 23, 2022 4:14 PM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

On November 21, 2022, John P. Sharp, Chief Financial Officer of PhaseBio Pharmaceuticals Inc. (NASDAQ: PHAS), informed the Company that he was resigning from his position, effective November 30, 2022, to pursue another employment opportunity.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes